HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Takayuki Kanaseki Selected Research
Takayuki Kanaseki Research Topics
Disease
76
Neoplasms (Cancer)
05/2024 - 02/2005
10
Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 02/2005
9
Sarcoma (Soft Tissue Sarcoma)
10/2023 - 01/2016
9
Neoplasm Metastasis (Metastasis)
09/2023 - 01/2013
8
Colonic Neoplasms (Colon Cancer)
09/2023 - 06/2011
7
Carcinoma (Carcinomatosis)
07/2023 - 01/2013
7
Testicular Neoplasms (Testicular Cancer)
01/2023 - 06/2012
6
Osteosarcoma (Osteogenic Sarcoma)
10/2023 - 01/2016
6
Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 06/2012
5
Lung Neoplasms (Lung Cancer)
01/2017 - 02/2010
4
Stomach Neoplasms (Stomach Cancer)
05/2024 - 11/2004
4
Breast Neoplasms (Breast Cancer)
11/2023 - 02/2005
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2023 - 01/2017
4
Melanoma (Melanoma, Malignant)
04/2023 - 02/2005
3
Squamous Cell Carcinoma of Head and Neck
09/2023 - 08/2002
3
Pancreatic Neoplasms (Pancreatic Cancer)
08/2019 - 01/2013
3
Adenocarcinoma
08/2019 - 02/2005
3
Hypoxia (Hypoxemia)
12/2016 - 05/2015
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2005 - 08/2002
2
Urinary Bladder Neoplasms (Bladder Cancer)
07/2023 - 04/2022
2
Granuloma
06/2023 - 03/2021
2
Microsatellite Instability
01/2022 - 01/2017
2
Tuberculosis (Tuberculoses)
03/2021 - 01/2021
2
Carcinogenesis
01/2021 - 01/2020
2
Adenocarcinoma of Lung
11/2020 - 01/2013
2
Glioma (Gliomas)
01/2019 - 03/2004
2
Pleural Effusion (Pleural Effusions)
01/2016 - 02/2010
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2024
1
Lymphoma (Lymphomas)
01/2024
1
Esophageal Squamous Cell Carcinoma
11/2023
1
Mouth Neoplasms (Oral Cancer)
09/2023
1
Skin Neoplasms (Skin Cancer)
04/2023
1
B-Cell Lymphoma (Lymphoma, B Cell)
02/2023
1
Prostatic Neoplasms (Prostate Cancer)
01/2022
1
Melena
07/2021
1
Massive Hepatic Necrosis
06/2021
1
Endometrial Neoplasms (Endometrial Cancer)
03/2021
Drug/Important Bio-Agent (IBA)
34
Peptides (Polypeptides)
IBA
05/2024 - 08/2002
33
Antigens
IBA
10/2023 - 02/2010
16
Immune Checkpoint Inhibitors
IBA
05/2024 - 01/2016
10
Proteins (Proteins, Gene)
FDA Link
01/2023 - 02/2005
8
HLA Antigens (Human Leukocyte Antigens)
IBA
05/2024 - 02/2010
8
Survivin
IBA
02/2020 - 02/2005
6
HLA-A24 Antigen
IBA
10/2020 - 02/2005
5
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
11/2023 - 01/2016
5
Histocompatibility Antigens Class I
IBA
01/2019 - 01/2013
4
Ligands
IBA
12/2022 - 01/2014
4
Oxidoreductases (Dehydrogenase)
IBA
04/2017 - 05/2015
4
Cancer Vaccines
IBA
01/2014 - 02/2005
3
Aldehyde Dehydrogenase
IBA
05/2024 - 01/2016
3
Neoplasm Antigens (Tumor Antigens)
IBA
06/2023 - 01/2014
3
Interferon-gamma (Interferon, gamma)
IBA
06/2023 - 03/2004
3
Aldehyde Dehydrogenase 1 Family
IBA
01/2022 - 04/2017
3
incomplete Freund's adjuvant
IBA
02/2020 - 06/2011
3
Messenger RNA (mRNA)
IBA
01/2020 - 01/2016
3
Protein Subunit Vaccines
IBA
08/2019 - 06/2011
3
Epitopes
IBA
01/2018 - 06/2011
3
MHC class II transactivator protein
IBA
11/2004 - 05/2003
2
Calcibiotic Root Canal Sealer
IBA
04/2024 - 01/2017
2
Complementary DNA (cDNA)
IBA
10/2023 - 01/2013
2
Odorant Receptors (Odorant Receptor)
IBA
09/2023 - 01/2016
2
Cisplatin (Platino)
FDA Link
Generic
07/2023 - 01/2023
2
Small Interfering RNA (siRNA)
IBA
04/2023 - 04/2016
2
Differentiation Antigens
IBA
04/2023 - 01/2023
2
Transcription Factors (Transcription Factor)
IBA
04/2023 - 08/2016
2
Immune Checkpoint Proteins
IBA
04/2023 - 04/2017
2
Formaldehyde (Formol)
FDA Link
02/2023 - 05/2012
2
Nivolumab
IBA
07/2021 - 06/2021
2
pembrolizumab
IBA
07/2021 - 11/2020
2
Photosensitizing Agents (Photosensitizers)
IBA
02/2021 - 01/2019
2
1-phenyl-3,3-dimethyltriazene (PDT)
IBA
02/2021 - 01/2019
2
B7-H1 Antigen
IBA
11/2020 - 04/2017
2
Biomarkers (Surrogate Marker)
IBA
09/2019 - 01/2017
2
Gemcitabine
FDA Link
08/2019 - 10/2018
2
Heat-Shock Proteins (Heat-Shock Protein)
IBA
03/2018 - 04/2014
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2016 - 01/2016
2
HLA-DR Antigens (HLA-DR)
IBA
11/2004 - 05/2003
1
Aldehydes
IBA
05/2024
1
NLR Proteins
IBA
11/2023
1
eribulin
FDA Link
11/2023
1
GTP-Binding Proteins (G-Protein)
IBA
09/2023
1
CEACAM1 Protein
IBA
04/2023
1
Paraffin
IBA
02/2023
1
Arachidonate 5-Lipoxygenase (5 Lipoxygenase)
IBA
02/2023
1
RNA (Ribonucleic Acid)
IBA
01/2023
1
Monophenol Monooxygenase (Tyrosinase)
IBA
01/2023
1
HLA-A*24:02 antigen
IBA
01/2023
1
MART-1 Antigen
IBA
01/2023
1
CTLA-4 Antigen
IBA
04/2022
1
Insulin (Novolin)
FDA Link
01/2022
1
Vaccines
IBA
12/2021
1
Long Noncoding RNA
IBA
11/2021
1
Ipilimumab
IBA
06/2021
1
Talaporfin (talaporfin sodium)
IBA
02/2021
Therapy/Procedure
35
Immunotherapy
05/2024 - 01/2013
27
Therapeutics
10/2023 - 11/2012
11
Drug Therapy (Chemotherapy)
05/2024 - 01/2013
7
Radiotherapy
05/2024 - 01/2013
2
Aftercare (After-Treatment)
03/2021 - 01/2013
1
Chemoradiotherapy
12/2022